Drug General Information
Drug ID
D09AOO
Former ID
DCL001141
Drug Name
ANAVEX 2-73
Indication Breast cancer [ICD9: 174, 175; ICD10:C50] Phase 2 [531153], [532266]
Alzheimer disease [ICD9: 331; ICD10:G30] Phase 1 [549727]
Company
Anavex
Structure
Download
2D MOL
Target and Pathway
Target(s) Sigma(1)-type opioid receptor Target Info Agonist [549727]
WikiPathways miR-targeted genes in squamous cell - TarBase
miR-targeted genes in lymphocytes - TarBase
References
Ref 531153Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma 1 (?1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative. J Psychopharmacol. 2011 Aug;25(8):1101-17.
Ref 532266Blockade of Tau hyperphosphorylation and Abeta?????? generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and ???receptor agonist, in a nontransgenic mouse model of Alzheimer's disease. Neuropsychopharmacology. 2013 Aug;38(9):1706-23.
Ref 5497272011 Pipeline of Anavex.
Ref 5497272011 Pipeline of Anavex.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.